Merus N.V (NASDAQ: MRUS) on Monday, plunged -2.07% from the previous trading day, before settling in for the closing price of $52.69. Within the past 52 weeks, MRUS’s price has moved between $19.81 and $61.61.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 7.00% over the last five years. The company achieved an average annual earnings per share of -2.71%. With a float of $59.23 million, this company’s outstanding shares have now reached $68.21 million.
The firm has a total of 229 workers. Let’s measure their productivity. In terms of profitability, gross margin is -105.38%, operating margin of -513.22%, and the pretax margin is -460.58%.
Merus N.V (MRUS) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Merus N.V is 13.17%, while institutional ownership is 88.44%. The most recent insider transaction that took place on Aug 21 ’24, was worth 135,000. In this transaction VP Controller, PAO of this company sold 2,500 shares at a rate of $54.00, taking the stock ownership to the 7,002 shares. Before that another transaction happened on Aug 20 ’24, when Company’s VP Controller, PAO sold 2,500 for $54.00, making the entire transaction worth $135,000. This insider now owns 7,002 shares in total.
Merus N.V (MRUS) Earnings and Forecasts
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.43 earnings per share (EPS) for the period topping the consensus outlook (set at -0.73) by 0.3. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.84 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.20% during the next five years compared to -18.50% drop over the previous five years of trading.
Merus N.V (NASDAQ: MRUS) Trading Performance Indicators
Merus N.V (MRUS) is currently performing well based on its current performance indicators. A quick ratio of 9.97 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 100.02.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.87, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -3.67 in one year’s time.
Technical Analysis of Merus N.V (MRUS)
Analysing the last 5-days average volume posted by the [Merus N.V, MRUS], we can find that recorded value of 0.38 million was lower than the volume posted last year of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 40.88%. Additionally, its Average True Range was 1.59.
During the past 100 days, Merus N.V’s (MRUS) raw stochastic average was set at 33.83%, which indicates a significant decrease from 52.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 29.78% in the past 14 days, which was lower than the 38.65% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.00, while its 200-day Moving Average is $47.78. Now, the first resistance to watch is $52.39. This is followed by the second major resistance level at $53.18. The third major resistance level sits at $53.93. If the price goes on to break the first support level at $50.85, it is likely to go to the next support level at $50.10. Should the price break the second support level, the third support level stands at $49.31.
Merus N.V (NASDAQ: MRUS) Key Stats
Market capitalization of the company is 3.52 billion based on 58,688K outstanding shares. Right now, sales total 43,950 K and income totals -154,940 K. The company made 7,330 K in profit during its latest quarter, and -50,040 K in sales during its previous quarter.
